Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer

Zeting Yuan(Shanghai University of Traditional Chinese Medicine), Ke Xu(Shanghai University)
British Journal of Cancer
March 16, 2020
Cited by 60


Related Papers